Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Uppercut Brands Inc (UCUT)

Uppercut Brands Inc (UCUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Home Point Capital: Q3 Earnings Snapshot

ANN ARBOR, Mich. (AP) _ Home Point Capital Inc. (HMPT) on Thursday reported third-quarter net income of $71.2 million.

UCUT : 0.3500 (-22.22%)
Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore

Silo Pharma could Utilize Data for Psilocybin Delivery potential to Central Nervous System

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)
Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications

Silo Pharma to Receive Upfront Payment Combination of Cash and Preferred Stock Totaling One Million Dollars

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)
AIKI : 3.56 (+0.28%)
Silo Pharma Inc. Receives One Million Dollars in Up Front Licensing Deal for its Psilocybin Cancer Therapeutic Applications in a Combination of Cash and Equities

Englewood Cliffs, NJ, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced...

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)
Silo Pharma, Inc. Enhances Scientific Advisory Board with Appointment of Dr. Charles B. Nemeroff of University of Texas at Austin

Englewood Cliffs, NJ, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced...

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)
Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham

NEW JERSEY, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its...

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)
Silo Pharma Comments on Recent Promotional and Trading Activities at Request of OTC Markets

NEW JERSEY , Dec. 04, 2020 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that...

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)
Silo Pharma, Inc. Expands Scientific Advisory Board with the Appointment of Dr. Joshua Woolley of University of California, San Francisco

NEW YORK , Nov. 16, 2020 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) today announced that its Board of Directors has named scientific research investigator Dr. Joshua Woolley, M.D. / Ph.D. to...

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)
Silo Pharma, Inc. Announces Filing of Three U.S. Provisional Patent Applications

Each Provisional Patent Application Relates to Psilocybin

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)
Silo Pharma, Inc. Launches Scientific Advisory Board with Appointment of Dr. Matthew Johnson of John Hopkins University

Industry Recognized Expert in Psychedelics and Related Safety Guidelines

UCUT : 0.3500 (-22.22%)
SILO : 1.8500 (unch)

Barchart Exclusives

2 Small-Cap Stocks With 40% to 60% Upside
Wall Street believes these two growth stocks will soar, driven by the demand for their products. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar